Category: Laser/Light-based Devices
Ousted CEO Federico Pignatelli turns the spotlight on new leadership at his former company after resigning from the board of directors.
Former Biolase (NSDQ:BIOL) CEO Federico Pignatelli isn't ready to put down his dukes after dropping his seat on the company's board of directors.
St. Jude Medical and Volcano agree to settle all litigation between them, putting to bed years of lawsuits over medical lasers and fractional flow reserve devices.
Biolase's scorned former CEO Federico Pignatelli retires from the board of directors, saying that he was effectively forced out by hostilities from other members.
Former Biolase (NSDQ:BIOL) CEO Federico Pignatelli, who was removed from the corner office by a court order earlier this year, also walked away from the company's board of directors.
LensAR secures another $8 million in an equity funding round in support of its laser-based cataract surgery systems.
Opthalmology devices maker LensAR secured $8 million in equity funding, according to an SEC filing dated July 31, 2014.
The Mass. Supreme Judicial Court denies St. Jude Medical's bid to overturn the portions of a lower court's ruling that went against it in its laser technology spat with Volcano Corp.
The highest court in Massachusetts largely denied
Scorned Biolase ex-CEO Federico Pignatelli withdraws his lawsuit as the company urges shareholders to welcome new leadership and deny his bid for re-election to the board.
Former Biolase (NSDQ:BIOL) CEO Federico Pignatelli agreed this week to withdraw his lawsuit against the dental devices maker, but he's still pursuing his personal investigation into the company's recent conduct.
Vascular Solutions agrees to pay $520,000 to settle a U.S. Justice Dept. probe without admitting any wrongdoing.
Vascular Solutions (NSDQ:VASC) issued a special statement this week after the U.S. Justice announced that it had won a $520,000 settlement after accusing the company of selling a medical device without proper FDA approval.